Altimmune (NASDAQ:ALT) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen lowered shares of Altimmune (NASDAQ:ALT – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday. Several other brokerages have also commented on ALT. HC Wainwright reissued a “buy” rating and issued a $12.00 price objective on shares of Altimmune in a report […]
Wall Street Zen lowered shares of Altimmune (NASDAQ:ALT – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday. Several other brokerages have also commented on ALT. HC Wainwright reissued a “buy” rating and issued a $12.00 price objective on shares of Altimmune in a report […]
